Medical Cannabis Patients With Sleep Problems Saw Greater Pain Improvements Over 12 Months
Among 1,139 UK chronic pain patients prescribed medical cannabis, those with co-occurring sleep impairment showed greater improvements in pain severity over 12 months compared to those without sleep problems.
Quick Facts
What This Study Found
Sleep-impaired patients showed improvements across all patient-reported outcomes at every follow-up. The sleep-impaired group had greater improvements in pain severity and sleep quality compared to the sleep-unimpaired group at all timepoints. No significant difference in adverse events between groups.
Key Numbers
1,139 patients (517 sleep-impaired, 622 unimpaired). Sleep-impaired group: significant improvements in all PROMs at all timepoints. Greater BPI pain severity improvement (P < 0.05) and sleep quality improvement (P < 0.001) vs unimpaired group. 2,817 total adverse events reported.
How They Did This
Prospective cohort from the UK Medical Cannabis Registry. 1,139 chronic pain patients divided by baseline sleep quality (impaired n=517, unimpaired n=622). Outcomes measured at 1, 3, 6, and 12 months using validated scales.
Why This Research Matters
Sleep and pain are deeply intertwined, and this study suggests medical cannabis may particularly benefit chronic pain patients who also have poor sleep.
The Bigger Picture
This is one of the largest and longest prospective studies of medical cannabis for chronic pain, from a real-world clinical registry rather than a controlled trial.
What This Study Doesn't Tell Us
Observational registry without a control group or placebo. Greater improvement in sleep-impaired group may reflect regression to the mean. Confounders including baseline pain severity. No randomization.
Questions This Raises
- ?Is the greater improvement in sleep-impaired patients due to cannabis treating both pain and sleep, or just regression to the mean?
- ?Would a randomized trial confirm these findings?
- ?What specific cannabis products were most effective?
Trust & Context
- Key Stat:
- Sleep-impaired patients had significantly greater pain improvement at all timepoints over 12 months
- Evidence Grade:
- Large prospective registry with 12-month follow-up; moderate because of observational design without placebo control.
- Study Age:
- 2025 publication from the UK Medical Cannabis Registry
- Original Title:
- UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment.
- Published In:
- Pain practice : the official journal of World Institute of Pain, 25(1), e13438 (2025)
- Authors:
- Datta, Ishita, Erridge, Simon(22), Holvey, Carl(10), Coomber, Ross, Guru, Rahul, Holden, Wendy, Darweish Medniuk, Alia, Sajad, Mohammed, Searle, Robert, Usmani, Azfer, Varma, Sanjay, Rucker, James J, Platt, Michael, Sodergren, Mikael H
- Database ID:
- RTHC-06298
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
Does medical cannabis help with both pain and sleep?
In this observational study, patients with both chronic pain and sleep problems improved on both measures over 12 months. However, without a control group, it is unclear how much of the improvement is due to cannabis versus other factors.
Were there many side effects?
2,817 adverse events were self-reported across both groups, with no significant difference between sleep-impaired and unimpaired patients. The study did not detail severity or specific adverse events in the abstract.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06298APA
Datta, Ishita; Erridge, Simon; Holvey, Carl; Coomber, Ross; Guru, Rahul; Holden, Wendy; Darweish Medniuk, Alia; Sajad, Mohammed; Searle, Robert; Usmani, Azfer; Varma, Sanjay; Rucker, James J; Platt, Michael; Sodergren, Mikael H. (2025). UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment.. Pain practice : the official journal of World Institute of Pain, 25(1), e13438. https://doi.org/10.1111/papr.13438
MLA
Datta, Ishita, et al. "UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment.." Pain practice : the official journal of World Institute of Pain, 2025. https://doi.org/10.1111/papr.13438
RethinkTHC
RethinkTHC Research Database. "UK medical cannabis registry: A clinical outcome analysis of..." RTHC-06298. Retrieved from https://rethinkthc.com/research/datta-2025-uk-medical-cannabis-registry
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.